ACBM

Acro Biomedical Co., Ltd. ACBM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACBM MRZM BSSP HDVY CNBX AFFY CEOS PBLA IGRW QEBR
6M -30.00 % 0.00 % 0.00 % 0.00 % -94.68 % 200.00 % -77.42 % -92.82 % 0.00 % 9 900.00 %
YTD -30.00 % -96.34 % 9 900.00 % 900.00 % -95.00 % 200.00 % -87.54 % -95.53 % 0.00 % -50.00 %
1Y -30.00 % -99.14 % 0.00 % 900.00 % -95.37 % 0.00 % -80.56 % -93.67 % 0.00 % 0.00 %
3Y -99.98 % -99.98 % 0.00 % -95.65 % -99.99 % 140.00 % -89.06 % -100.00 % 0.00 % -98.46 %
5Y -99.98 % -99.99 % 0.00 % -99.73 % -100.00 % -98.90 % 16.67 % -100.00 % -90.00 % -99.96 %
10Y -99.98 % -99.70 % -95.24 % -99.62 % -99.99 % -97.37 % -41.67 % -100.00 % -98.00 % -99.90 %
From the beginning -99.98 % -99.97 % -99.98 % -99.99 % -100.00 % -99.99 % -99.95 % -100.00 % -100.00 % -99.88 %

Dividend

Affymax, Inc.